Literature DB >> 32567039

Topical instillation of triamcinolone acetonide-loaded emulsomes for posterior ocular delivery: statistical optimization and in vitro-in vivo studies.

Rakhee Kapadia1, Kinjal Parikh1, Mahendra Jain1, Krutika Sawant2.   

Abstract

The objective of the present investigation was to formulate and characterize a novel lipid-based carrier-emulsomes loaded with triamcinolone acetonide (TA)/Nile red (NR) for non-invasive delivery to the posterior segment of the eye upon topical application. To optimize and delineate the effect of independent variables on dependent variables, Box-Behnken design (BBD) was adopted. The optimized batch was characterized for size, zeta potential, surface morphology by transmission electron microscopy, drug-excipient interaction by differential scanning calorimetry, osmolarity, pH, ex vivo transcorneal permeation, and stability studies. A short-term exposure (STE) test was performed on Statens Seruminstitut Rabbit Corneal (SIRC) cell lines to evaluate the in vitro ocular irritation. Precorneal retention study was performed in rabbit eyes. Confocal microscopy was used for ocular distribution studies in mice eye by preparing dye (Nile red)-loaded formulations. The surface response and contour plots along with ANOVA results demonstrated an interaction between the factors. The optimized batch had particle size of 131.17 ± 3.17 nm and entrapment efficiency of 71.56 ± 4.19%. TEM image showed unimodal, nano-sized emulsomes. TA-loaded emulsomes exhibited higher transcorneal permeation as compared to drug solution. In vitro irritation studies confirmed the safety of excipients for ophthalmic use. Fluorescence microscopic images obtained after ocular distribution studies showed strong fluorescence in inner and outer plexiform layers of the retina in comparison to dye solution confirming the delivery of dye to the posterior segment of mice eye after topical ocular instillation. Graphical abstract.

Entities:  

Keywords:  Emulsomes; Posterior ocular delivery; SIRC cell line; Topical instillation, HET-CAM; Triamcinolone acetonide

Mesh:

Substances:

Year:  2021        PMID: 32567039     DOI: 10.1007/s13346-020-00810-8

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   4.617


  33 in total

Review 1.  Ocular drug delivery.

Authors:  Ripal Gaudana; Hari Krishna Ananthula; Ashwin Parenky; Ashim K Mitra
Journal:  AAPS J       Date:  2010-05-01       Impact factor: 4.009

Review 2.  New techniques for drug delivery to the posterior eye segment.

Authors:  Esther Eljarrat-Binstock; Jacob Pe'er; Abraham J Domb
Journal:  Pharm Res       Date:  2010-02-13       Impact factor: 4.200

Review 3.  Novel nanosystems for the treatment of ocular inflammation: Current paradigms and future research directions.

Authors:  Lida Lalu; Vishakha Tambe; Deepak Pradhan; Kritika Nayak; Suchandra Bagchi; Rahul Maheshwari; Kiran Kalia; Rakesh Kumar Tekade
Journal:  J Control Release       Date:  2017-07-27       Impact factor: 9.776

4.  Axitinib-Loaded Poly(Lactic-Co-Glycolic Acid) Nanoparticles for Age-Related Macular Degeneration: Formulation Development and In Vitro Characterization.

Authors:  Priya Narvekar; Priyanka Bhatt; Gulimirerouzi Fnu; Vijaykumar Sutariya
Journal:  Assay Drug Dev Technol       Date:  2019 May/Jun       Impact factor: 1.738

5.  Intravitreal triamcinolone for intraocular inflammation and associated macular edema.

Authors:  Steven M Couch; Sophie J Bakri
Journal:  Clin Ophthalmol       Date:  2009-06-02

6.  Antileishmanial efficacy of amphotericin B bearing emulsomes against experimental visceral leishmaniasis.

Authors:  Swati Gupta; Anuradha Dube; Suresh P Vyas
Journal:  J Drug Target       Date:  2007-07       Impact factor: 5.121

Review 7.  A review on recent drug delivery systems for posterior segment of eye.

Authors:  Kritika Nayak; Manju Misra
Journal:  Biomed Pharmacother       Date:  2018-09-05       Impact factor: 6.529

8.  Inhalable liposomal dry powder of gemcitabine-HCl: Formulation, in vitro characterization and in vivo studies.

Authors:  Manit Gandhi; Tosha Pandya; Ravi Gandhi; Sagar Patel; Rajashree Mashru; Ambikanandan Misra; Hemal Tandel
Journal:  Int J Pharm       Date:  2015-10-21       Impact factor: 5.875

Review 9.  Steroid-induced Glaucoma: An Avoidable Irreversible Blindness.

Authors:  Sonia Phulke; Sushmita Kaushik; Savleen Kaur; S S Pandav
Journal:  J Curr Glaucoma Pract       Date:  2017-08-05

Review 10.  Nanotechnology-based strategies for treatment of ocular disease.

Authors:  Yuhua Weng; Juan Liu; Shubin Jin; Weisheng Guo; Xingjie Liang; Zhongbo Hu
Journal:  Acta Pharm Sin B       Date:  2016-11-18       Impact factor: 11.413

View more
  1 in total

Review 1.  Fluorescent Nanosystems for Drug Tracking and Theranostics: Recent Applications in the Ocular Field.

Authors:  Elide Zingale; Alessia Romeo; Salvatore Rizzo; Cinzia Cimino; Angela Bonaccorso; Claudia Carbone; Teresa Musumeci; Rosario Pignatello
Journal:  Pharmaceutics       Date:  2022-04-28       Impact factor: 6.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.